228 related articles for article (PubMed ID: 31102333)
1. CTHRC1 expression in primary biliary cholangitis.
Li YK; Li YM; Li Y; Wei YR; Zhang J; Li B; You ZR; Chen Y; Huang BY; Miao Q; Wang QX; Peng YS; Gershwin ME; Tang RQ; Bian ZL; Ma X
J Dig Dis; 2019 Jul; 20(7):371-376. PubMed ID: 31102333
[TBL] [Abstract][Full Text] [Related]
2. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
Corpechot C; El Naggar A; Poujol-Robert A; Ziol M; Wendum D; Chazouillères O; de Lédinghen V; Dhumeaux D; Marcellin P; Beaugrand M; Poupon R
Hepatology; 2006 May; 43(5):1118-24. PubMed ID: 16628644
[TBL] [Abstract][Full Text] [Related]
3. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
Kowdley KV; Knox TA; Kaplan MM
Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
[TBL] [Abstract][Full Text] [Related]
6. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.
Bian Z; Miao Q; Zhong W; Zhang H; Wang Q; Peng Y; Chen X; Guo C; Shen L; Yang F; Xu J; Qiu D; Fang J; Friedman S; Tang R; Gershwin ME; Ma X
J Autoimmun; 2015 Sep; 63():76-87. PubMed ID: 26238209
[TBL] [Abstract][Full Text] [Related]
8. Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
Dastych M; Husová L; Aiglová K; Fejfar T; Dastych M
Scand J Clin Lab Invest; 2021 Apr; 81(2):116-120. PubMed ID: 33428478
[TBL] [Abstract][Full Text] [Related]
9. Role of cell autophagy in the generation of IgM and hepatic fibrosis in primary biliary cholangitis.
Lian C; Zhao Y; Sun J; Zhao L; Zhang F
Clin Rheumatol; 2020 Nov; 39(11):3499-3506. PubMed ID: 32382831
[TBL] [Abstract][Full Text] [Related]
10. Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.
Bauer A; Habior A
Front Immunol; 2022; 13():885229. PubMed ID: 35529854
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
Lyberopoulou A; Chachami G; Gatselis NK; Kyratzopoulou E; Saitis A; Gabeta S; Eliades P; Paraskeva E; Zachou K; Koukoulis GK; Mamalaki A; Dalekos GN; Simos G
PLoS One; 2015; 10(8):e0135486. PubMed ID: 26270641
[TBL] [Abstract][Full Text] [Related]
12. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
[TBL] [Abstract][Full Text] [Related]
13. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
14. TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A; Dooley S; Dewidar B; Hammad S; Dediulia T; Werle J; Hartwig V; Ghafoory S; Woelfl S; Korhonen H; Janicot M; Wosikowski K; Itzel T; Teufel A; Schuppan D; Stojanovic A; Cerwenka A; Nittka S; Piiper A; Gaiser T; Beraza N; Milkiewicz M; Milkiewicz P; Brain JG; Jones DEJ; Weiss TS; Zanger UM; Ebert M; Meindl-Beinker NM
Gut; 2020 Sep; 69(9):1677-1690. PubMed ID: 31992593
[TBL] [Abstract][Full Text] [Related]
15. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
16. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
[TBL] [Abstract][Full Text] [Related]
19. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.
Pihusch R; Rank A; Göhring P; Pihusch M; Hiller E; Beuers U
J Hepatol; 2002 Nov; 37(5):548-55. PubMed ID: 12399218
[TBL] [Abstract][Full Text] [Related]
20. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
